Streetbeat News

Stock Prices

RNAZ

TransCode Therapeutics has announced the initiation of a Phase 1 study for its lead therapeutic candidate, TTX-MC138. This study marks a significant milestone for the company as it advances its clinical pipeline.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:06 am

WMT

Walmart has raised its FY25 adjusted EPS outlook to $2.35-$2.43 from the previous $2.23-$2.37, aligning closely with the $2.43 estimate. The company also updated its consolidated net sales growth to 3.75%-4.75% and adjusted operating income growth to 6.5%-8.0%.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:05 am

CVAC

CureVac has advanced its cancer vaccine candidate CVGBM to Part B of its Phase 1 study in patients with resected glioblastoma. The first patient has been administered the dose-confirmation, and Part B is expected to include up to 20 patients to gather extended data on safety, tolerability, and immunogenicity.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:05 am

GAMB

Gambling.com Group shares are trading higher following better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:05 am

GAMB

Gambling.com Group (NASDAQ:GAMB) reported Q2 2024 adjusted EPS of $0.20, beating the $0.12 estimate by 66.67%. Sales were $30.541M, surpassing the $26.909M estimate by 13.50%. Both EPS and sales showed significant year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:04 am

WMT

Walmart's Q3 outlook reveals revenue projections between $164.58B and $166.17B, falling short of the $167.11B estimate. Adjusted EPS is expected to be $0.51-$0.52, below the $0.55 estimate. Consolidated net sales are projected to increase by 3.25% to 4.25%, and operating income by 3.0% to 4.5%.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:03 am

WMT

Walmart shares are trading higher following better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:03 am

VRTS

Virtus Investment Partners has announced an 18% increase in its quarterly dividend, raising it from $1.90 to $2.25 per share. The dividend will be paid on November 13, 2024, to shareholders of record as of October 31, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:02 am

MLSS

Milestone Scientific (AMEX:MLSS) reported Q2 sales of $1.85 million, missing the analyst consensus estimate of $2.52 million by 26.47%. This represents a 36.32% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:01 am

GRAB

Grab Holdings reported its Q2 2024 financial results with a GAAP EPS of $(0.01) and sales of $664 million, missing the estimated $669.25 million.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:01 am